LOW IL-1-BETA PRODUCTION IN LEUKEMIC-CELLS FROM PROGRESSIVE B-CELL CHRONIC LEUKEMIA (B-CLL)

被引:15
|
作者
AGUILARSANTELISES, M
AMADOR, JF
MELLSTEDT, H
JONDAL, M
机构
[1] KAROLINSKA INST,DEPT IMMUNOL,BOX 60400,S-10401 STOCKHOLM 60,SWEDEN
[2] KAROLINSKA HOSP,RADIUM HEMMET,DEPT ONCOL,S-10401 STOCKHOLM,SWEDEN
[3] NATL INST ONCOL,HAVANA,CUBA
关键词
D O I
10.1016/0145-2126(89)90048-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:937 / 942
页数:6
相关论文
共 50 条
  • [21] Expression of HLA-G in patients with B-cell chronic lymphocytic leukemia (B-CLL)
    Giannopoulos, K.
    Dmoszynska, A.
    Bojarska-Junak, A.
    Schmitt, M.
    Rolinski, J.
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2008, 46 (04) : 457 - 460
  • [22] Telomere length has prognostic impact in B-cell chronic lymphocytic leukemia (B-CLL).
    Ricca, I
    Drandi, D
    Rocci, A
    Compagno, M
    Francese, R
    Mantoan, B
    Castellino, C
    Ficara, F
    Vallet, S
    Dell'Aquila, M
    Santo, L
    Caracciolo, D
    Bergui, L
    Gallamini, A
    Bazzan, M
    Marinone, C
    Boccadoro, M
    Tarella, C
    Ladetto, M
    BLOOD, 2004, 104 (11) : 275B - 275B
  • [23] Allogeneic stem cell transplantation from related or unrelated donors for B-cell chronic lymphocytic leukemia (B-CLL).
    Pavletic, ZS
    Arrowsmith, ER
    Bierman, PJ
    Goodman, SA
    Vose, JM
    Tarantolo, SR
    Stein, RS
    Greer, JP
    Kollath, JP
    Weisenburger, DD
    Wolff, SN
    Armitage, JO
    Bishop, MR
    BLOOD, 1998, 92 (10) : 288A - 288A
  • [24] ACTIVITY OF TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
    LAGNEAUX, L
    DELFORGE, A
    BRON, D
    STRYCKMANS, P
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 798 - 798
  • [25] EXCESSIVE PRODUCTION OF TGF-BETA BY BONE-MARROW STROMAL CELLS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) INHIBITS GROWTH OF HEMATOPOIETIC PRECURSORS AND IL-6 PRODUCTION
    DELFORGE, A
    LAGNEAUX, L
    DORVAL, C
    BRON, D
    BOSMANS, E
    STRYCKMANS, P
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1090 - 1090
  • [26] MDR1 gene polymorphism associates with susceptibility to B-cell chronic lymphocytic leukemia (B-CLL) and determines P-glycoprotein activity in B-CLL tumour cells.
    Jamroziak, K
    Smolewski, P
    Balcerczak, E
    Cebula, B
    Kowalczyk, M
    Szmigielska-Kaplon, A
    Mirowski, M
    Mlynarski, W
    Robak, T
    BLOOD, 2003, 102 (11) : 598A - 599A
  • [27] INTERLEUKIN-1 (IL-1-ALPHA AND IL-1-BETA) INDUCES DIFFERENTIATION/ACTIVATION OF B-CELL CHRONIC LYMPHOID LEUKEMIA-CELLS
    TAKEUCHI, H
    KATAYAMA, I
    CYTOKINE, 1994, 6 (03) : 243 - 246
  • [28] Mean telomere length and telomerase activity of peripheral blood cells from patients with B-cell chronic lymphocytic leukemia (B-CLL).
    Tsilika, A
    Pappa, VI
    Taffas, T
    Chalevelakis, G
    Kontsioti, F
    Psara, E
    Economopoulos, T
    Papageorgiou, E
    Dervenoulas, J
    Kapsimali, V
    Pappa, M
    Rapis, S
    Skandalis, A
    BLOOD, 1999, 94 (10) : 538A - 538A
  • [29] A CASE OF CLASSICAL KAPOSIS-SARCOMA IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
    CONTU, L
    CARCASSI, C
    LANASA, G
    ZURRIDA, SM
    SIRIGU, F
    DELGIACCO, S
    CERIMELE, D
    LONGINOTTI, M
    PITZUS, F
    TUMORI, 1986, 72 (04) : 365 - 374
  • [30] Clinical significance of CD69 expression in B-cell Chronic Lymphocytic Leukemia (B-CLL)
    Del Poeta, G.
    Del Principe, M., I
    Luciano, F.
    Maurillo, L.
    Buccisano, F.
    Gattei, V
    Niscola, P.
    Venditti, A.
    Imo Consalvo, M.
    Catalano, G.
    de Fabritiis, P.
    Amadori, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 108 - 108